|
GPATCH4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.85019996493219E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.73170050416149E-10 |
| Normal-vs-Stage2 |
2.849600E-02 |
| Normal-vs-Stage3 |
1.72620000005175E-06 |
| Normal-vs-Stage4 |
9.031800E-04 |
| Stage1-vs-Stage2 |
7.215700E-02 |
| Stage1-vs-Stage3 |
2.727800E-01 |
| Stage1-vs-Stage4 |
4.189800E-01 |
| Stage2-vs-Stage3 |
2.872600E-01 |
| Stage2-vs-Stage4 |
3.798000E-01 |
| Stage3-vs-Stage4 |
9.936200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.1786000054268E-08 |
| Normal-vs-AfricanAmerican |
2.32919999999526E-05 |
| Normal-vs-Asian |
3.616100E-04 |
| Caucasian-vs-AfricanAmerican |
5.276200E-01 |
| Caucasian-vs-Asian |
8.000200E-01 |
| AfricanAmerican-vs-Asian |
7.153200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.91719995013796E-09 |
| Normal-vs-Female |
2.30690000435629E-08 |
| Male-vs-Female |
1.774960E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.91159985010836E-10 |
| Normal-vs-Age(41-60Yrs) |
7.37280003715313E-09 |
| Normal-vs-Age(61-80Yrs) |
3.142100E-03 |
| Normal-vs-Age(81-100Yrs) |
2.563400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.355800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.560800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.133440E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.253700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.082600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.129200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.459400E-01 |
| Classical-VS-Follicular |
2.936500E-02 |
| Classical-VS-Other |
3.048000E-02 |
| Classical-VS-Normal |
4.79819999954501E-07 |
| Tall-VS-Follicular |
5.634800E-01 |
| Tall-VS-Other |
9.017500E-02 |
| Tall-VS-Normal |
5.93949999999621E-05 |
| Follicular-VS-Other |
2.278000E-01 |
| Follicular-VS-Normal |
5.13700000315254E-08 |
| Other-VS-Normal |
2.12279999999287E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.15270000106338E-08 |
| Normal-vs-N1 |
1.20830000005512E-07 |
| N0-vs-N1 |
4.446300E-02 |
|
|
